BioCatalyst

RGX-202 — catalyst calendar

1 verified catalyst event(s) referencing RGX-202, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 26d
ESTIMATED
 READOUT
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular D
Phase 2/3 · Duchenne Muscular Dystrophy
 RGNX REGENXBIO Inc. RGX-202 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.